What if a diabetes drug could also lower your risk of colon cancer? A massive new study in JAMA Oncology may have found an important clue.
Researchers analyzed health records from over one million people with type 2 diabetes who had never taken diabetes medication before. They wanted to see whether GLP-1 drugs like semaglutide or liraglutide were linked to a lower chance of developing colorectal cancer.



